Baum Charles M

President,Founder,Head of R&D at Mirati Therapeutics, Inc.; Director at ARRAY BIOPHARMA INC

Sold, on record
$49.3M
Dollars the filings state
Form 4 sales
17
Latest Jan 4, 2023
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
5
Plan not stated
0
No plan
12
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Jan 4, 2023Plan not stated

    Mirati Therapeutics, Inc.

    Sold 2.1% of their holdings

    $170k3,648 shares at $46.60

    Filed Jan 5, 2023Form 4

  2. Dec 21, 2022Plan not stated

    Mirati Therapeutics, Inc.

    Sold 5% of their holdings

    $367k9,092 shares at $40.42

    Filed Dec 21, 2022Form 4

  3. Nov 28, 2022Unusual

    Mirati Therapeutics, Inc.

    Sold 35.1% of their holdings

    $6.9M69,256 shares at $100.00

    Filed Nov 28, 2022Form 4

  4. Jan 18, 2022Plan not stated

    Mirati Therapeutics, Inc.

    Sold 1.9% of their holdings

    $303k2,517 shares at $120.48

    Filed Jan 18, 2022Form 4

  5. Jan 4, 2022Plan not stated

    Mirati Therapeutics, Inc.

    Sold 3.9% of their holdings

    $608k4,114 shares at $147.75

    Filed Jan 6, 2022Form 4

  6. Dec 3, 2021Unusual

    Mirati Therapeutics, Inc.

    Sold 29.5% of their holdings

    $6.3M47,204 shares at $133.20

    Filed Dec 3, 2021Form 4

  7. Jun 18, 2021Unusual

    Mirati Therapeutics, Inc.

    Sold 26.2% of their holdings

    $6.6M40,000 shares at $165.46

    Filed Jun 21, 2021Form 4

  8. Jan 6, 2021Plan not stated

    Mirati Therapeutics, Inc.

    Sold 4.9% of their holdings

    $949k4,511 shares at $210.39

    Filed Jan 8, 2021Form 4

  9. Dec 18, 2020Unusual

    Mirati Therapeutics, Inc.

    Sold 28.2% of their holdings

    $9.4M40,000 shares at $234.48

    Filed Dec 21, 2020Form 4

  10. Apr 17, 2020Unusual

    Mirati Therapeutics, Inc.

    Sold 27.3% of their holdings

    $3.6M40,000 shares at $90.33

    Filed Apr 20, 2020Form 4

10 of 17

Every transaction

Every transaction on a Form 4 or Form 5 by Baum Charles M
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Jun 17, 2026Jun 22, 2026ACRVDirectorAwardedStock Option (Right to Buy)20,27520,275SEC
Jun 4, 2026Jun 5, 2026PMVPDirectorAwardedStock Option (right to buy)42,00042,000SEC
May 18, 2026May 20, 2026ACRVDirectorAwarded9,3669,366SEC
Jun 13, 2025Jun 17, 2025ACRVDirectorAwardedStock Option (Right to Buy)20,27520,275SEC
Jun 5, 2025Jun 9, 2025PMVPDirectorAwardedStock Option (right to buy)33,50033,500SEC
Jan 8, 2025Jan 8, 2025PSTXDirectorTendered78,6000SEC
Jan 8, 2025Jan 8, 2025PSTXDirectorReturned to the companyStock Option (Right to Buy)111,7000SEC
Jun 20, 2024Jun 24, 2024ACRVDirectorAwardedStock Option (Right to Buy)20,27520,275SEC
Jun 17, 2024Jun 18, 2024PSTXDirectorAwardedStock Option (Right to buy)27,35027,350SEC
Jun 17, 2024Jun 18, 2024PSTXDirectorAwarded19,65078,600SEC
Jun 6, 2024Jun 10, 2024PMVPDirectorAwardedStock Option (right to buy)67,50067,500SEC
Jan 23, 2024Jan 23, 2024Mirati Therapeutics, Inc.Founder, President, and CEOReturned to the companyOption to Purchase Common Stock718,2130SEC
Jan 23, 2024Jan 23, 2024Mirati Therapeutics, Inc.Founder, President, and CEOReturned to the company237,8710SEC
Dec 29, 2023Jan 3, 2024Mirati Therapeutics, Inc.Interim CEOAwarded20,425$58.75$1.2M247,700SEC
Aug 9, 2023Aug 10, 2023Mirati Therapeutics, Inc.Interim CEOAwarded54,054$37.00$2M227,275SEC
Jun 22, 2023Jun 28, 2023ACRVDirectorAwardedStock Option (Right to Buy)32,50032,500SEC
Jun 15, 2023Jun 16, 2023PSTXDirectorAwardedStock Option (Right to buy)27,35027,350SEC
Jun 15, 2023Jun 16, 2023PSTXDirectorAwarded19,65058,950SEC
Jun 8, 2023Jun 12, 2023PMVPDirectorAwardedStock Option (right to buy)21,50021,500SEC
Jan 20, 2023Jan 24, 2023Mirati Therapeutics, Inc.President,Founder,Head of R&DAwardedEmployee Stock Option (Right to Buy)7,5207,520SEC
Jan 20, 2023Jan 24, 2023Mirati Therapeutics, Inc.President,Founder,Head of R&DAwarded4,444173,221SEC
Jan 4, 2023Jan 5, 2023Mirati Therapeutics, Inc.President,Founder,Head of R&DSold3,648$46.60$170k168,777SEC
Dec 21, 2022Dec 21, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DSold9,092$40.42$367k172,425SEC
Dec 19, 2022Dec 21, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DAwarded53,618181,517SEC
Nov 28, 2022Nov 28, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DSold69,256$100.00$6.9M127,899SEC
Nov 28, 2022Nov 28, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DExercised or settledEmployee Stock Option (Right to Buy)69,25669,258SEC
Nov 28, 2022Nov 28, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DExercised options69,256$17.41$1.2M197,155SEC
Jun 16, 2022Jun 16, 2022PSTXDirectorAwardedStock Option (Right to Buy)57,00057,000SEC
Jun 16, 2022Jun 16, 2022PSTXDirectorAwarded39,30039,300SEC
Jun 2, 2022Jun 6, 2022PMVPDirectorAwardedStock Option (right to buy)19,50019,500SEC
Jan 18, 2022Jan 18, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DSold2,517$120.48$303k127,899SEC
Jan 18, 2022Jan 18, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DExercised or settledEmployee Stock Option (Right to Buy)3,703178,052SEC
Jan 18, 2022Jan 18, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DExercised options3,703$27.00$100k130,416SEC
Jan 14, 2022Jan 18, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DAwardedEmployee Stock Option (Right to Buy)42,32542,325SEC
Jan 14, 2022Jan 18, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DAwarded25,543126,713SEC
Jan 4, 2022Jan 6, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DSold4,114$147.75$608k101,170SEC
Dec 16, 2021Dec 17, 2021Mirati Therapeutics, Inc.President & CEOGift7,430105,284SEC
Dec 3, 2021Dec 3, 2021Mirati Therapeutics, Inc.President & Head of R&DSold47,204$133.20$6.3M112,714SEC
Dec 3, 2021Dec 3, 2021Mirati Therapeutics, Inc.President & Head of R&DExercised or settledEmployee Stock Option (Right to Buy)47,2040SEC
Dec 3, 2021Dec 3, 2021Mirati Therapeutics, Inc.President & Head of R&DExercised options47,204$8.49$401k159,918SEC
Jun 18, 2021Jun 21, 2021Mirati Therapeutics, Inc.President & CEOSold40,000$165.46$6.6M112,714SEC
Jun 18, 2021Jun 21, 2021Mirati Therapeutics, Inc.President & CEOExercised or settledEmployee Stock Option (Right to Buy)40,00047,204SEC
Jun 18, 2021Jun 21, 2021Mirati Therapeutics, Inc.President & CEOExercised options40,000$8.49$340k152,714SEC
Jun 2, 2021Jun 9, 2021PMVPDirectorAwardedStock Option (right to buy)16,33316,333SEC
Apr 5, 2021Apr 7, 2021PMVPDirectorAwardedStock Option (right to buy)32,67732,677SEC
Jan 26, 2021Jan 28, 2021Mirati Therapeutics, Inc.President & CEOExercised or settledEmployee Stock Option (Right to Buy)2,292100,273SEC
Jan 26, 2021Jan 28, 2021Mirati Therapeutics, Inc.President & CEOExercised options2,292$5.40$12k112,714SEC
Jan 19, 2021Jan 20, 2021Mirati Therapeutics, Inc.President & CEOExercised or settledEmployee Stock Option (Right to Buy)3,245181,755SEC
Jan 19, 2021Jan 20, 2021Mirati Therapeutics, Inc.President & CEOExercised options3,245$27.00$88k110,422SEC
Jan 15, 2021Jan 20, 2021Mirati Therapeutics, Inc.President & CEOAwardedEmployee Stock Option (Right to Buy)30,74230,742SEC
Page 1

Sales and notices (17)

Form 144 notices and Form 4 sales by Baum Charles M
Source
Jan 4, 2023Jan 5, 2023Mirati Therapeutics, Inc.President,Founder,Head of R&DForm 4 sale3,648$170k2.1%Plan not statedSEC
Dec 21, 2022Dec 21, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DForm 4 sale9,092$367k5.0%Plan not statedSEC
Nov 28, 2022Nov 28, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DForm 4 sale69,256$6.9M35.1%UnusualSEC
Jan 18, 2022Jan 18, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DForm 4 sale2,517$303k1.9%Plan not statedSEC
Jan 4, 2022Jan 6, 2022Mirati Therapeutics, Inc.President,Founder,Head of R&DForm 4 sale4,114$608k3.9%Plan not statedSEC
Dec 3, 2021Dec 3, 2021Mirati Therapeutics, Inc.President & Head of R&DForm 4 sale47,204$6.3M29.5%UnusualSEC
Jun 18, 2021Jun 21, 2021Mirati Therapeutics, Inc.President & CEOForm 4 sale40,000$6.6M26.2%UnusualSEC
Jan 6, 2021Jan 8, 2021Mirati Therapeutics, Inc.President & CEOForm 4 sale4,511$949k4.9%Plan not statedSEC
Dec 18, 2020Dec 21, 2020Mirati Therapeutics, Inc.President & CEOForm 4 sale40,000$9.4M28.2%UnusualSEC
Apr 17, 2020Apr 20, 2020Mirati Therapeutics, Inc.President & CEOForm 4 sale40,000$3.6M27.3%UnusualSEC
Aug 22, 2019Aug 23, 2019Mirati Therapeutics, Inc.President & CEOForm 4 sale51,810$4.5M44.0%UnusualSEC
Feb 25, 2019Feb 27, 2019Mirati Therapeutics, Inc.President & CEOForm 4 sale51,810$3.9M44.0%UnusualSEC
Aug 23, 2018Aug 24, 2018Mirati Therapeutics, Inc.President & CEOForm 4 sale51,810$3M50.4%UnusualSEC
Feb 23, 2018Feb 27, 2018Mirati Therapeutics, Inc.President & CEOForm 4 sale51,810$1.5M50.4%UnusualSEC
Feb 9, 2018Feb 12, 2018ARRAY BIOPHARMA INCDirectorForm 4 sale50,000$845k83.3%UnusualSEC
Mar 28, 2017Mar 30, 2017ARRAY BIOPHARMA INCDirectorForm 4 sale25,000$232k83.3%UnusualSEC
May 8, 2015May 12, 2015ARRAY BIOPHARMA INCDirectorForm 4 sale25,000$185k100.0%UnusualSEC